(Q44287991)

1 December 2017

Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia (English)

1 reference

1 December 2017

Gram-negative bacteria

0 references

author name string

Sutep Jaruratanasirikul

series ordinal

1

1 reference

PubMed ID

12542901

1 December 2017

Somchai Sriwiriyajan

series ordinal

2

1 reference

PubMed ID

12542901

1 December 2017

Natnicha Ingviya

series ordinal

3

1 reference

1 December 2017

1 December 2002

1 reference

Journal of Pharmacy and Pharmacology

1 December 2017

1 reference

1 December 2017

54

1 reference

1 December 2017

12

1 reference

1 December 2017

1693-1696

1 reference

High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine

1 December 2017

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Choosing between the new cephalosporin antibiotics: a pharmacodynamic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

Continuous infusion of cefazolin is superior to intermittent dosing in decreasing infection after hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702171

21 January 2018

Identifiers

DOI

10.1211/002235702171

1 reference

1 December 2017

1 reference

PubMed ID

12542901